Three Scenarios of the In Vitro Diagnostics Market, 2019-2023: Business-as-Usual, Economic Austerity, Technological Breakthroughs

July 2019 | 255 pages | ID: TB548DD0087EN
Venture Planning Group

Abstracts

This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:

• To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.
• To identify key strategic decisions that will have to be made in the future.
• To enhance corporate ability to develop realistic contingency plans.
• To prepare executives to accommodate radically different operating climates and reduce surprises.
• To challenge accepted perceptions of the future diagnostics market.

This report is an invaluable strategic planning resource for corporate, marketing and R& executives. The strategic issues explored in the report include:

• How will the future reimbursement changes affect individual market segments?
• Will the industry consolidate, decentralize, or undergo a bimodal transformation?
• What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?
• How will the future technological advances affect the major market segment?
• Which companies will enter the market and which will not survive?

These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.

Contains 255 pages and 32 tables

Contents

I. INTRODUCTION

II. EXECUTIVE SUMMARY

A. BUSINESS-AS-USUAL SCENARIO
B. ECONOMIC AUSTERITY SCENARIO
C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO

III. CONCLUSIONS AND RECOMMENDATIONS

IV.THE SCENARIOS

A. BUSINESS-AS-USUAL SCENARIO
  1. Business Environment
    a. Health Care Expenditures
    b. Cost-Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
      PPOs
      HMOs
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
      Chronic Illnesses
      Disease Incidence
      Susceptibility to Iatrogenesis
      Multiple Illness Cases
    l. Laboratory Regulations
    m. The FDA Reform
  2. Outlook for the In Vitro Diagnostics Market
    a. Government Regulations
    b. Centralized Testing
      Hospitals
      Commercial Laboratories
      Blood Banks
      Public Health Laboratories
    c. Decentralized Testing
      Personal Testing
      Physician Offices/Group Practices
      Ancillary Hospital Locations
        ERs
        ORs
        ICUs/CCUs
      Cancer Clinics
      Ambulatory Care Centers
      Surgery Centers
      Nursing Homes
      Birth Centers
  3. Strategic Implications
    a. Testing Patterns
      Test Utilization
      Pre-Admission Testing
      Inpatient Testing
      Outpatient Testing
  4. Market Segments
    a. Chemistry and Immunoassay
      Introduction
      Future Situation
    b. Microbiology and Serology
      Introduction
      Future Situation
    c. Hematology and Flow Cytometry
      Introduction
      Future Situation
    d. Histology and Cytology
      Introduction
      Future Situation
    e. Coagulation
      Introduction
      Future Situation
    f. Urinalysis
      Introduction
      Future Situation
    g. Blood Banking
      Introduction
      Future Situation
  5.Technologies
    a. Genomics
      Introduction
      Future Situation
    b. Proteomics
      Introduction
      Future Situation
    c. DNA Probes
      Introduction
      Future Situation
    d. Biochips/Microarrays
      Introduction
      Future Situation
    e. Monoclonal Antibodies
      Introduction
      Future Situation
    f. Solid Phase Chemistry
      Introduction
      Future Situation
    g. Biosensors
      Introduction
      Future Situation
    h. Automation and Robotics
      Introduction
      Future Situation
    i. Computer-Aided Diagnosis
      Introduction
      Future Situation
  6.The New Marketplace
    a. Purchasing Influences
    b. Marketing Strategies
    c. Joint Ventures, Mergers and Licensing
    d. Import-Export
    e. Potential Market Entrants
    f. Who May Not Survive?
B. ECONOMIC AUSTERITY SCENARIO
  1. Business Environment
    a. Socio-Political Climate
• Cost-Consciousness
• Government Actions
• Three-Tier System
• Health Rationing
• Voucher System
• Health IRA
    b. Hospital Closures
    c. Hospital Utilization
    d. Hospital Reorganization
    e. Physician Regulations
    f. Wellness Programs
    g. Corporate Responses
    h. Academic Research
  2. Outlook for the In Vitro Diagnostics Market
    a. Test Utilization
• Ordering Practices
• Documentation
• Recertification
    b.Technology Regulations
    c. New Laboratory Ventures
    d. Computers
    e. Industrial Medicine
    f. Insurance Companies
    g. Test Volume and Market Size
  3. Strategic Implications
    a. Testing Patterns
• Pre-Admission Testing
• Inpatient Testing
• Outpatient Testing
    b. Market Segments
• Chemistry and Immunoassay
• Microbiology and Serology
• Hematology and Flow Cytometry
• Histology and Cytology
• Coagulation
• Urinalysis
• Blood Banking
    c.Technologies
• Genomics
• Proteomics
• DNA Probes
• Biochips/Microarrays
• Monoclonal Antibodies and Immunoassays
• Automation and Robotics
• Solid Phase Chemistry
• Biosensors
• Computer-Aided Diagnosis
    d.The New Marketplace
• Purchasing Influences
• Marketing Strategies
• Joint Ventures, Mergers and Licensing
• Import-Export
• Potential Market Entrants
• Who May Not Survive?
C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
  1. Business Environment
    a. Political/Regulatory Climate
    b. R & D Funding
    c. Industry-Government Relationship
    d. Industry-University Ventures
    e.Technological Environment
    f. Testing Decentralization
    g. Health Care Expenditures
    h. Physician Population
    i. Hospital Indicators
  2. Outlook for the In Vitro Diagnostics Market
    a. Overview
    b. Genomics
    c. Proteomics
    d. DNA and RNA Probes
    e. Biochips/Microarrays
    f. Monoclonal Antibodies
    g. Immunoassays
    h. Information Technology
    i. Laboratory Automation and Robotics
    j. Solid Phase Chemistry
    k. Biosensors
    l. Holography
    m. Pharmaceuticals
  3. Strategic Implications
    a.Testing Patterns
• Pre-Admission Testing
• Inpatient Testing
• Outpatient Testing
• Test Volume and Market Size
    b. Market Segments
• Chemistry and Immunoassay
• Microbiology and Serology
• Hematology and Flow Cytometry
• Histology and Cytology
• Coagulation
• Urinalysis
• Blood Banking
    c.The New Marketplace
• Purchasing Influences
• Marketing Strategies
• Joint Ventures, Mergers and Licensing
• Import-Export
• Potential Market Entrants
• Who May Not Survive?

V.APPENDICES: METHODOLOGY

A.The Delphi
B. Cross-Impact Analysis
C. Substitution Modeling

List Of Tables

LIST OF TABLES

Executive Summary Table I: Business-As-Usual Scenario, Growth Areas in Clinical Laboratory Testing
Executive Summary Table II: Economic Austerity Scenario, Growth Areas in Clinical Laboratory Testing
Executive Summary Table III: Technological Breakthroughs Scenario, Growth Areas in Clinical Laboratory Testing
Executive Summary Table IV: Market Size by Location
Executive Summary Table V: Market Size by Laboratory Discipline
Table-1: Business-As-Usual Scenario, Health Care Costs by Expenditure Type
Table-2: Business-As-Usual Scenario, HMO and PPO Enrollment
Table-3: Business-As-Usual Scenario, Selected Hospital Statistics
Table-4: Business-As-Usual Scenario,Total Population and Physician Demographics
Table-5: Business-As-Usual Scenario,Test Volume by Location
Table-6: Business-As-Usual Scenario,Test Distribution by Location
Table-7: Business-As-Usual Scenario, Market Size by Location
Table-8: Business-As-Usual Scenario,Typical Pre-Admission Tests
Table-9: Business-As-Usual Scenario,Test Volume by Laboratory Discipline
Table-10: Business-As-Usual Scenario, Market Size By Laboratory Discipline
Table-11: Economic Austerity Scenario, Selected Hospital Statistics
Table-12: Economic Austerity Scenario, HMO and PPO Enrollment
Table-13: Economic Austerity Scenario,Total Population and Physician Demographics
Table-14: Economic Austerity Scenario, Major Categories of Overutilized Tests
Table-15: Economic Austerity Scenario, Test Volume by Location
Table-16: Economic Austerity Scenario,Test Distribution by Location
Table-17: Economic Austerity Scenario, Market Size by Location
Table-18: Economic Austerity Scenario,Timing Requirements for Selected Laboratory Tests
Table-19: Economic Austerity Scenario,Test Volume by Laboratory Discipline
Table-20: Economic Austerity Scenario, Market Size by Laboratory Discipline
Table-21: Technological Breakthroughs Scenario, HMO and PPO Enrollment
Table-22: Technological Breakthroughs Scenario,Total Population and Physician Demographics
Table-23: Technological Breakthroughs Scenario, Selected Hospital Statistics
Table-24: Technological Breakthroughs Scenario, Test Volume by Location
Table-25: Technological Breakthroughs Scenario, Test Distribution by Location
Table-26: Technological Breakthroughs Scenario, Market Size by Location
Table-27: Technological Breakthroughs Scenario, Test Volume by Laboratory Discipline
Table-28: Technological Breakthroughs Scenario, Market Size by Laboratory Discipline